Company intelligence / Profile preview

Tianjin HengJia Biotechnology Development

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Tianjin HengJia Biotechnology Development is an established biotechnology company focused on the development and manufacturing of in vitro diagnostic (IVD) reagents and related technologies. Their current operations are in the commercial stage, primarily serving the clinical diagnostic market in China.

Therapeutic areas: OncologyCardiovascularInfectious Diseases
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Tianjin HengJia Biotechnology Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin HengJia Biotechnology Development.

Explore the full profile